Research Summary

My non-clinical work focuses on developing and evaluating risk assessment tools for breast cancer and using those tools to efficiently use screening technologies and preventive therapies to decrease the burden of breast cancer in our community.

I also perform technology assessments and support cost-effectiveness modeling and budget impact analyses for new medications, medical devices, and health system interventions for the Institute for Clinical and Economic Review.

Education

Dartmouth College, Hanover, NH, BA, 06/1983, Math; Philosophy
San Francisco State University, 05/1989, Pre-medical classed
University of California, San Francisco, MD, 06/1994, Medicine
University of California, San Francisco, 06/1997, Internal Medicine
University of California, San Francisco, Postdoctoral, 06/1999, Research/Epidmiology

Honors & Awards

  • 2013
    UCSF Research Mentoring Award
  • 2009
    Society of General Internal Medicine- CA Region- Outstanding Clinician Investigator Award
  • 2003
    Robert Crede Award for Clinical Research, UCSF Division of General Internal Medicine
  • 2002-2004
    Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Faculty Scholar
  • 1994
    Alpha Omega Alpha, UCSF
  • 1990-1994
    Regents Scholarship, UCSF
  • 1983
    Summa Cum Laude, Dartmouth College
  • 1982
    Phi Beta Kappa, Dartmouth College
  • 1979-1983
    Rufous Choate Scholar, Dartmouth College
  • 1979-1983
    IBM Thomas J. Watson Scholar

Selected Publications

  1. Tice JA, Mandrik O, Thokala P, Fotheringham J, Pearson SD. The effectiveness and value of belimumab and voclosporin for lupus nephritis. J Manag Care Spec Pharm. 2021 Oct; 27(10):1495-1499.  View on PubMed
  2. Esserman L, Eklund M, Veer LV, Shieh Y, Tice J, Ziv E, Blanco A, Kaplan C, Hiatt R, Fiscalini AS, Yau C, Scheuner M, Naeim A, Wenger N, Lee V, Heditsian D, Brain S, Parker BA, LaCroix AZ, Madlensky L, Hogarth M, Borowsky A, Anton-Culver H, Kaster A, Olopade OI, Sheth D, Garcia A, Lancaster R, Plaza M. The WISDOM study: a new approach to screening can and should be tested. Breast Cancer Res Treat. 2021 Oct; 189(3):593-598.  View on PubMed
  3. Trabert B, Geczik AM, Bauer DC, Buist DSM, Cauley JA, Falk RT, Gierach GL, Hue TF, Lacey JV, LaCroix AZ, Michels KA, Tice JA, Xu X, Brinton LA, Dallal CM. Association of Endogenous Pregnenolone, Progesterone, and Related Metabolites with Risk of Endometrial and Ovarian Cancers in Postmenopausal Women: The B∼FIT Cohort. Cancer Epidemiol Biomarkers Prev. 2021 Aug 31.  View on PubMed
  4. Huilgol YS, Keane H, Shieh Y, Hiatt RA, Tice JA, Madlensky L, Sabacan L, Fiscalini AS, Ziv E, Acerbi I, Che M, Anton-Culver H, Borowsky AD, Hunt S, Naeim A, Parker BA, van 't Veer LJ, Athena Breast Health Network Investigators and Advocate Partners , Esserman LJ. Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry. NPJ Breast Cancer. 2021 Aug 03; 7(1):102.  View on PubMed
  5. Keane H, Huilgol YS, Shieh Y, Tice JA, Belkora J, Sepucha K, Shibley WP, Wang T, Che M, Goodman D, Ozanne E, Fiscalini AS, Esserman LJ. Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial. NPJ Breast Cancer. 2021 Jun 17; 7(1):78.  View on PubMed
  6. Qaseem A, Etxeandia-Ikobaltzeta I, Fitterman N, Williams JW, Kansagara D, Clinical Guidelines Committee of the American College of Physicians , Batur P, Cooney TG, Crandall CJ, Hicks LA, Lin JS, Maroto M, Tice J, Tufte JE, Vijan S, Williams JW. Appropriate Use of High-Flow Nasal Oxygen in Hospitalized Patients for Initial or Postextubation Management of Acute Respiratory Failure: A Clinical Guideline From the American College of Physicians. Ann Intern Med. 2021 07; 174(7):977-984.  View on PubMed
  7. Qaseem A, Etxeandia-Ikobaltzeta I, Mustafa RA, Kansagara D, Fitterman N, Wilt TJ, Clinical Guidelines Committee of the American College of Physicians , Batur P, Cooney TG, Crandall CJ, Hicks LA, Lin JS, Maroto M, Tice J, Tufte JE, Vijan S, Williams JW. Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emergency Department or Inpatient Settings: A Clinical Guideline From the American College of Physicians. Ann Intern Med. 2021 07; 174(7):985-993.  View on PubMed
  8. Michels KA, Geczik AM, Bauer DC, Brinton LA, Buist DSM, Cauley JA, Dallal CM, Falk RT, Hue TF, Lacey JV, LaCroix AZ, Tice JA, Xu X, Trabert B. Endogenous Progestogens and Colorectal Cancer Risk among Postmenopausal Women. Cancer Epidemiol Biomarkers Prev. 2021 06; 30(6):1100-1105.  View on PubMed
  9. Tice JA, Whittington MD, Campbell JD, Pearson SD. The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorder. J Manag Care Spec Pharm. 2021 Apr; 27(4):528-532.  View on PubMed
  10. Tice JA, Kuntz KM, Wherry K, Seidner M, Rind DM, Pearson SD. The effectiveness and value of novel treatments for cystic fibrosis. J Manag Care Spec Pharm. 2021 Feb; 27(2):276-280.  View on PubMed
  11. Tice JA, Halalau A, Burke H. Vitamin D Does Not Prevent Cancer or Cardiovascular Disease: The VITAL Trial : Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Gordon D, Copeland T, D'Agostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE (2019) Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N Engl J Med 380 (1):33-44. J Gen Intern Med. 2020 Aug 12.  View on PubMed
  12. Shieh Y, Tice JA. Medications for Primary Prevention of Breast Cancer. JAMA. 2020 07 21; 324(3):291-292.  View on PubMed
  13. Tice JA, Guzauskas GF, Hansen RN, Herron-Smith S, Segel C, Walsh JME, Pearson SD. The Effectiveness and Value of Oral Immunotherapy and Viaskin Peanut for Peanut Allergy. J Manag Care Spec Pharm. 2020 May; 26(5):620-623.  View on PubMed
  14. Trabert B, Bauer DC, Buist DSM, Cauley JA, Falk RT, Geczik AM, Gierach GL, Hada M, Hue TF, Lacey JV, LaCroix AZ, Tice JA, Xu X, Dallal CM, Brinton LA. Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women. JAMA Netw Open. 2020 04 01; 3(4):e203645.  View on PubMed
  15. Tice JA, Campbell JD, Synnott PG, Walsh JME, Kumar VM, Whittington M, Adair E, Rind D, Pearson SD. The Effectiveness and Value of Biologic Therapies for the Treatment of Uncontrolled Asthma. J Manag Care Spec Pharm. 2019 May; 25(5):510-514.  View on PubMed
  16. Antoniou A, Anton-Culver H, Borowsky A, Broeders M, Brooks J, Chiarelli A, Chiquette J, Cuzick J, Delaloge S, Devilee P, Dorval M, Easton D, Eisen A, Eklund M, Eloy L, Esserman L, Garcia-Closas M, Goldgar D, Hall P, Knoppers BM, Kraft P, La Croix A, Madalensky L, Mavaddat N, Mittman N, Nabi H, Olopade O, Pashayan N, Schmidt M, Shieh Y, Simard J, Stover-Fiscallini A, Tice JA, Van't Veer L, Wenger N, Wolfson M, Yau C, Ziv E. A response to "Personalised medicine and population health: breast and ovarian cancer". Hum Genet. 2019 Mar; 138(3):287-289.  View on PubMed
  17. Tice JA, Bissell MCS, Miglioretti DL, Gard CC, Rauscher GH, Dabbous FM, Kerlikowske K. Validation of the breast cancer surveillance consortium model of breast cancer risk. Breast Cancer Res Treat. 2019 Jun; 175(2):519-523.  View on PubMed
  18. Whittington MD, McQueen RB, Ollendorf DA, Kumar VM, Chapman RH, Tice JA, Pearson SD, Campbell JD. Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma. JAMA Netw Open. 2019 02 01; 2(2):e190035.  View on PubMed
  19. Zimmermann M, Brouwer E, Tice JA, Seidner M, Loos AM, Liu S, Chapman RH, Kumar V, Carlson JJ. Disease-Modifying Therapies for Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis. CNS Drugs. 2018 12; 32(12):1145-1157.  View on PubMed
  20. Whittington MD, McQueen RB, Ollendorf DA, Kumar VM, Chapman RH, Tice JA, Pearson SD, Campbell JD. Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia. JAMA Pediatr. 2018 12 01; 172(12):1161-1168.  View on PubMed

Go to UCSF Profiles, powered by CTSI